- Home
- PBBK vs MAIA Comparison
PBBK vs MAIA Comparison
Compare PBBK & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- MAIA
- Stock Information
- Founded
- PBBK 1919
- MAIA 2018
- Country
- PBBK United States
- MAIA United States
- Employees
- PBBK N/A
- MAIA N/A
- Industry
- PBBK Banks
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- MAIA Health Care
- Exchange
- PBBK Nasdaq
- MAIA Nasdaq
- Market Cap
- PBBK 45.2M
- MAIA 46.7M
- IPO Year
- PBBK N/A
- MAIA 2022
- Fundamental
- Price
- PBBK $18.02
- MAIA $1.78
- Analyst Decision
- PBBK
- MAIA
- Analyst Count
- PBBK 0
- MAIA 0
- Target Price
- PBBK N/A
- MAIA N/A
- AVG Volume (30 Days)
- PBBK 4.6K
- MAIA 425.1K
- Earning Date
- PBBK 08-13-2025
- MAIA 08-08-2025
- Dividend Yield
- PBBK N/A
- MAIA N/A
- EPS Growth
- PBBK 12.16
- MAIA N/A
- EPS
- PBBK 0.83
- MAIA N/A
- Revenue
- PBBK $12,804,000.00
- MAIA N/A
- Revenue This Year
- PBBK N/A
- MAIA N/A
- Revenue Next Year
- PBBK N/A
- MAIA N/A
- P/E Ratio
- PBBK $22.57
- MAIA N/A
- Revenue Growth
- PBBK 5.21
- MAIA N/A
- 52 Week Low
- PBBK $13.85
- MAIA $1.40
- 52 Week High
- PBBK $19.05
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- PBBK 66.45
- MAIA 50.97
- Support Level
- PBBK $16.49
- MAIA $1.60
- Resistance Level
- PBBK $19.05
- MAIA $1.95
- Average True Range (ATR)
- PBBK 0.59
- MAIA 0.10
- MACD
- PBBK 0.14
- MAIA 0.00
- Stochastic Oscillator
- PBBK 91.23
- MAIA 54.49
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.